Cargando…
The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced
BACKGROUND: The global pandemic COVID-19 caused by the new coronavirus SARS-CoV-2 has already caused about 1.4 million deaths, and to date, there are no effective or direct antiviral vaccines. Some vaccines are in the last stages of testing. Overall mortality rates vary between countries, for exampl...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838235/ https://www.ncbi.nlm.nih.gov/pubmed/34777865 http://dx.doi.org/10.1186/s43066-021-00082-y |